| 3FQ9: reference: Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications., Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA, J Biol Chem. 2009 Nov 13;284(46):32178-87. Epub 2009 Sep 22. PMID: 19773552 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).